NCT03132155 2024-05-24
QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
NantPharma, LLC
Phase 2 Terminated
Clinical Trials
6 trialsNCT02344810 2023-05-25
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
Eastern Cooperative Oncology Group
Phase 1/2 Withdrawn
NCT01253707 2022-11-07
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Amgen
Phase 1 Completed
NCT02096666 2021-12-28
A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects
Amgen
Phase 1/2 Completed
NCT03147976 2019-08-28
QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors
NantPharma, LLC
Phase 2 Withdrawn
NCT02016534 2017-07-02
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
Amgen
Phase 2 Terminated